Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003083604 | SCV003460317 | uncertain significance | not provided | 2021-08-27 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine with methionine at codon 1519 of the COL4A4 protein (p.Thr1519Met). The threonine residue is highly conserved and there is a moderate physicochemical difference between threonine and methionine. This variant is present in population databases (rs770268591, ExAC 0.005%). This variant has not been reported in the literature in individuals affected with COL4A4-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV003083604 | SCV005078431 | uncertain significance | not provided | 2024-04-25 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV005028186 | SCV005653773 | uncertain significance | Autosomal recessive Alport syndrome; Hematuria, benign familial, 1 | 2024-05-20 | criteria provided, single submitter | clinical testing |